Society of Gynecologic Oncology Annual Meeting
Adjuvant therapy does not extend survival in high-risk endometrial cancer
Postoperative systemic or radiation therapy did not extend survival for women with high-risk stage I endometrial cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Paclitaxel-cisplatin combination extends PFS in advanced epithelial ovarian cancer
The addition of paclitaxel to cisplatin in a hyperthermic intraperitoneal chemotherapy regimen doubled PFS among women with advanced epithelial ovarian cancer undergoing interval debulking surgery, study results showed.
Interventions overcome endometrial cancer clinical trial inequity in Deep South
Interventions designed to improve care for Black women with endometrial cancer can help overcome clinical trial inequities, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Rucaparib significantly extends PFS in advanced, relapsed BRCA-mutated ovarian cancer
Rucaparib significantly prolonged PFS compared with chemotherapy for women with BRCA-mutated advanced, relapsed ovarian cancer, according to a study presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Levonorgestrel intrauterine device induces response in early endometrial cancer, precancer
Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.
Survey: Most female gynecologic oncologists have faced workplace bullying, harassment
Most female gynecologic oncologists who responded to an internet-based survey reported having experienced workplace bullying, according to a presentation at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Time to surgery linked to survival among women with high-grade endometrial cancer
Regionalization of care for high-grade endometrial cancer in Ontario had no negative effect on surgical wait times, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Preterm birth risk higher among women with early cervical cancer
Women with early cervical cancer who conceived at least 3 months after fertility-sparing surgery had a high live birth rate, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Olaparib maintenance confers durable PFS benefit in advanced BRCA-mutated ovarian cancer
Olaparib maintenance significantly extended 5-year PFS for women with advanced BRCA-positive ovarian cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Chemotherapy for gynecologic cancer does not increase COVID-19 hospitalization, death
Chemotherapy did not increase risk for hospitalization or death due to COVID-19 among women with gynecologic cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.